Gene: RECK
Official Full Name: reversion inducing cysteine rich protein with kazal motifsprovided by HGNC
Gene Summary: The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03618 | RECK Knockout cell line (HeLa) | Human | RECK | 1:3~1:6 | Negative | Online Inquiry |
KO03619 | RECK Knockout cell line (HCT 116) | Human | RECK | 1:2~1:4 | Negative | Online Inquiry |
KO03620 | RECK Knockout cell line (HEK293) | Human | RECK | 1:3~1:6 | Negative | Online Inquiry |
KO03621 | RECK Knockout cell line (A549) | Human | RECK | 1:3~1:4 | Negative | Online Inquiry |
RECK Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the functional role of the RECK (Reversion-inducing Cysteine-rich Protein with Kazal Motifs) gene in various biological contexts. These cell lines serve as valuable tools for researchers seeking to elucidate the molecular pathways influenced by RECK, a gene known for its contributions to processes such as cell adhesion, migration, and cancer metastasis. By utilizing advanced CRISPR/Cas9 technology, these cell lines effectively eliminate the expression of the RECK gene, allowing for precise investigation into its physiological functions and associated disease mechanisms.
The primary mechanism of action in our RECK Gene Knockout Cell Lines involves the knockout of the RECK gene, leading to alterations in matrix metalloproteinase (MMP) regulation and extracellular matrix (ECM) remodeling. This inhibition of RECK has been implicated in tumor progression and metastasis, making these cell lines particularly significant for cancer research. They provide a robust platform for studying the effects of RECK loss on cellular behavior under various conditions, facilitating the development of targeted therapeutic strategies in oncology and regenerative medicine.
The scientific importance of these cell lines extends into several applications, including drug discovery, biomarker identification, and therapeutic efficacy evaluations in preclinical models. Researchers and clinicians can leverage these knockout cell lines to better understand RECK-related pathologies and to explore potential interventions in cancer treatment.
Compared to traditional approaches that rely on siRNA or shRNA knockdowns, RECK Gene Knockout Cell Lines offer a permanent loss-of-function model, thereby eliminating transient effects and enhancing experimental reproducibility. Furthermore, their compatibility with high-throughput screening assays makes them an indispensable resource for laboratories aiming to accelerate their research timelines.
Incorporating RECK Gene Knockout Cell Lines into research not only enhances the validity of experimental findings but also empowers scientists with a deeper understanding of gene function in health and disease. As an organization renowned for its commitment to advancing biological research, we provide meticulously validated products that meet the highest standards of scientific integrity and reproducibility, ensuring our clients remain at the forefront of their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.